EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pathological mechanisms and treatment strategies for immune checkpoint inhibitor-associated myocarditis: insights from single-cell sequencing

Yameng Zhao, Yang Lu, Tinglan Fu, Jinying Zhang, Junnan Tang

Basic Research in Cardiology · 11.01.2026 · 121 (2) · 301-319

DOI: 10.1007/s00395-025-01156-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Basic Research in Cardiology, online erschienen am 11.01.2026. Verfasst von Yameng Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Myocarditis, Single-Cell Analysis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China, Henan Province Key R&D Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors have significantly advanced cancer treatment, but they can lead to immune-related adverse events. Among these, immune checkpoint inhibitor-associated myocarditis (ICI-M) represents a rare yet severe cardiotoxicity. The underlying pathogenesis of ICI-M is not fully elucidated, necessitating deeper mechanistic investigation. Traditional bulk sequencing technology measures average gene expression across entire cell populations, which affects the interpretation of gene function in complex tissues. In contrast, single-cell sequencing technology represents a transformative advancement by enabling multi-omics analysis at single-cell resolution. This cutting-edge approach offers key insights into disease mechanisms by accurately identifying the composition changes and gene expression characteristics of specific cell populations in ICI-M. This review summarizes recent advances in single-cell sequencing applications in ICI-M research and highlights its role in elucidating pathogenesis. Building on these mechanistic insights, the review further discusses emerging targeted strategies that aim to mitigate cardiac inflammation without compromising antitumor immunity, offering a promising framework for precision intervention in ICI-M.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsMyocarditisSingle-Cell AnalysisHumansAnimalsSingle-Cell Gene Expression Analysis

Stichwörter der Autor:innen

Immune checkpoint inhibitorImmune checkpoint inhibitor-associated myocarditisSingle-cell sequencingTargeted therapy

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Key Laboratory of Cardiac Injury and Repair of Henan Province, Zhengzhou, 450052, Henan, China.
  • Henan Province Clinical Research Center for Cardiovascular Diseases, Zhengzhou, 450052, Henan, China.
  • Henan Province Academy of Cardiovascular Disease Prevention and Treatment, Henan, 450052, China.
  • State Key Laboratory of Metabolic Dysregulation & Prevention and Treatment of Esophageal Cancer, Tianjian Laboratory of Advanced Biomedical Sciences, Academy of Medical Sciences, Zhengzhou, 450001, Henan, China.
  • Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China. jyzhang@zzu.edu.cn.

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation of China
  • Henan Province Key R&D Program
  • Henan Province Science and Technology Research Joint Project
  • Innovation Scientists and Technicians Troop Construction Projects of Henan Province
  • Henan Provincial Clinical Medical Scientist Training Project
  • Funding for Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University

Zitieren

APA

Zhao, Y., Lu, Y., Fu, T., Zhang, J., & Tang, J. (2026). Pathological mechanisms and treatment strategies for immune checkpoint inhibitor-associated myocarditis: insights from single-cell sequencing. Basic Research in Cardiology, 121(2), 301-319. https://doi.org/10.1007/s00395-025-01156-3

Vancouver

Zhao Y, Lu Y, Fu T, Zhang J, Tang J. Pathological mechanisms and treatment strategies for immune checkpoint inhibitor-associated myocarditis: insights from single-cell sequencing. Basic Research in Cardiology. 2026;121(2):301-319. doi:10.1007/s00395-025-01156-3

BibTeX
@article{Zhao2026,
  author = {Zhao, Yameng and Lu, Yang and Fu, Tinglan and Zhang, Jinying and Tang, Junnan},
  title = {Pathological mechanisms and treatment strategies for immune checkpoint inhibitor-associated myocarditis: insights from single-cell sequencing},
  journal = {Basic Research in Cardiology},
  year = {2026},
  volume = {121},
  number = {2},
  pages = {301--319},
  doi = {10.1007/s00395-025-01156-3}
}
Kostenlos starten →